Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dyadic International
(NQ:
DYAI
)
1.450
+0.080 (+5.83%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dyadic International
< Previous
1
2
3
4
5
6
Next >
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
April 12, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic International Earnings Perspective: Return On Capital Employed
March 30, 2023
Via
Benzinga
Dyadic to Present at World Vaccine Congress Washington 2023
March 30, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Earnings Outlook For Dyadic International
March 28, 2023
Via
Benzinga
Recap: Dyadic International Q1 Earnings
May 12, 2022
Dyadic International (NASDAQ:DYAI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
India Funds Affordable COVID-19 Vaccine Candidate Using Dyadic's Platform
April 13, 2022
Via
Benzinga
Why Phibro Shares Are Trading Higher Today?
February 10, 2022
Phibro Animal Health Corp (NASDAQ: PAHC) and Dyadic International Inc (NASDAQ: DYAI) have entered into an
Via
Benzinga
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
March 15, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
March 07, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
March 01, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 10, 2023
Via
Benzinga
Dyadic to Participate in Two Upcoming Investor Conferences
February 02, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
January 24, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Announces Sale of Equity Interest in Alphazyme
January 19, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023
Dyadic's executive management to attend the J.P. Morgan 41st Annual Healthcare Conference and the 6th Annual BFC Global Healthcare BD and Investment Conference from January 8-12 in San Francisco, CA...
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
December 14, 2022
From
Dyadic International, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Dyadic to Present at Upcoming Industry and Investor Events in November
November 07, 2022
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
October 27, 2022
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Receives Regulatory Approval to Initiate Phase 1 Clinical Trial to Demonstrate Clinical Safety and Efficacy in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
October 27, 2022
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential
October 04, 2022
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic International: Q2 Earnings Insights
August 10, 2022
Dyadic International (NASDAQ:DYAI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Dyadic International
August 09, 2022
Dyadic International (NASDAQ:DYAI) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
July 27, 2022
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic International Earnings Perspective: Return On Capital Employed
March 30, 2022
Dyadic International (NASDAQ:DYAI) brought in sales totaling $313.29 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 145.67%, resulting in a loss of $4.21...
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For March 29, 2022
March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Via
Benzinga
A Preview Of Dyadic International's Earnings
March 28, 2022
Dyadic International (NASDAQ:DYAI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Dyadic...
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
This Vaccine Stock Is Now On Janssen Pharmaceuticals, J&J, The White House's Radar
January 04, 2022
Dyadic International shares were up over 6% on January 3rd. Shares are up over 35% in the last month.
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.